Burger King has removed its most famous sandwich, the Whopper, from discount menus and would raise prices again this year to offset higher costs.
The fast-food chain, which caters to lower-income customers, used to offer the Whopper in its two for $5 deal and could still offer limited discounts on the burger in the future.
Jose Cil, CEO of Restaurant Brands, Burger King's parent, said the iconic Whopper has "been on this core discount platform for too long,"
Burger King also said it would stop selling some less-popular menu items altogether, including sundaes, whipped toppings, and chocolate milk.
Cil declined to provide timelines for overall price hikes in 2022.
Cost for shipping, labor, and commodities including chicken, coffee, and cooking oils have increased amid COVID-19 related disruptions, prompting restaurant chains to raise prices.
The Toronto, Ontario-based Restaurant Brands reported total revenue of $1.55 billion, above estimates of $1.52 billion.
The US.-listed shares of Restaurant Brands rose over 3 percent after it topped results estimates for the fourth quarter ended Dec. 31, led by soaring online sales and same-store sales growth at Burger King in the US and Tim Hortons in Canada.
Restaurant Brands posted per-share earnings of 74 cents in the fourth quarter, surpassing Refinitiv estimates of 69 cents.


Ukraine Faces Pressure to Introduce VAT on Low-Value Imports to Secure IMF Funding
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Gold Prices Drop Amid Iran War Concerns, Rising Oil Costs, and Hawkish Central Bank Signals
U.S. and EU Strengthen Critical Minerals Partnership to Reduce China Dependence
Yen Strengthens as BOJ Signals Rate Hikes; Asian Currencies Slip Ahead of Fed Meeting
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Oil Price Forecasts Rise for 2026 as Middle East Supply Risks Persist
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Trump Urges Iran to Sign Nuclear Deal Amid Ongoing Conflict and Port Blockade
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
US Sanctions Target Iran’s Shadow Banking Network and Terror Financing
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Gold Prices Dip Ahead of Fed Decision Amid Rising Middle East Tensions
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 



